FSSNX
Price
$28.08
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
MASMX
Price
$11.58
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

FSSNX vs MASMX

Header iconFSSNX vs MASMX Comparison
Open Charts FSSNX vs MASMXBanner chart's image
Fidelity Small Cap Index
Price$28.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Madison Small Cap A
Price$11.58
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSSNX vs MASMX Comparison Chart
Loading...
VS
FSSNX vs. MASMX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and MASMX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. MASMX (184M). FSSNX pays higher dividends than MASMX: FSSNX (1.36) vs MASMX (0.00). FSSNX was incepted earlier than MASMX: FSSNX (13 years) vs MASMX (5 years). MASMX is a more actively managed with annual turnover of: 39.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than MASMX: FSSNX (0) vs MASMX (1000). MASMX annual gain was more profitable for investors over the last year : 23.97 vs. FSSNX (22.65). FSSNX return over 5 years is better than : 44.62 vs. MASMX (12.92).
FSSNXMASMXFSSNX / MASMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years5 years-
Gain YTD9.97213.91472%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.3B184M14,837%
Annual Yield % from dividends1.360.00-
Returns for 1 year22.6523.9795%
Returns for 3 years0.65-20.94-3%
Returns for 5 years44.6212.92345%
Returns for 10 years84.2436.25232%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.